Rohan Beckwith
About Rohan Beckwith
Rohan Beckwith Vice President of Chemistry
Rohan Beckwith is the Vice President of Chemistry. In this role, he is responsible for overseeing and directing the chemistry division, with a focus on innovative research and development in synthetic organic chemistry and molecular glue degrader platforms. His extensive experience in the field provides invaluable leadership within the organization.
Rohan Beckwith Education and Expertise
Rohan Beckwith holds a Ph.D. in synthetic organic chemistry from the University of Nottingham, U.K., and an MSci. Chem from Bristol University, U.K. His education has equipped him with a robust foundation in chemical research and development. Beckwith further honed his expertise during his postdoctoral training with Prof. Huw Davies, where he focused on rhodium carbenoid-mediated C-H activation, a specialized area within the field of synthetic organic chemistry.
Rohan Beckwith Background in Chemical Biology
Before his current role, Rohan Beckwith served as a Director in the Chemical Biology and Therapeutics group at the Novartis Institutes for BioMedical Research. In this capacity, he was instrumental in developing a molecular glue degrader platform and led several drug discovery programs. His efforts resulted in the successful delivery of a clinical candidate. Beckwith's work spanned various therapeutic areas, including HECT E3 ligase inhibitors and Wnt pathway modulators.
Rohan Beckwith Achievements in Drug Discovery
Rohan Beckwith has made significant contributions to the field of drug discovery. At Novartis, he developed molecular glue degraders for CRBN, VHL, and DCAF15 E3 ligases. His leadership in establishing drug discovery programs has been pivotal, as he worked on over 20 research projects across multiple therapeutic areas. His efforts in modulating RNA processing and targeting HECT E3 ligase inhibitors have been particularly noteworthy.